Relationship between some acute phase reactants and the bath ankylosing spondylitis disease activity index in patients with ankylosing spondylitis

被引:33
作者
Yildirim, K [1 ]
Erdal, A [1 ]
Karatay, S [1 ]
Melikoglu, MA [1 ]
Ugur, M [1 ]
Senel, K [1 ]
机构
[1] Ataturk Univ, Sch Med, Dept Phys Med & Rehabil, TR-25240 Erzurum, Turkey
关键词
acute phase reactants; ankylosing spondylitis; disease activity index;
D O I
10.1097/01.SMJ.0000066946.56322.3C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The aims of this study were to investigate a possible relationship between the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and some acute phase reactant (APR) levels in patients with ankylosing spondylitis (AS). Methods: Twenty outpatients who fulfilled the modified New York criteria for AS were included in the study. Laboratory activity was assessed by examining erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), haptoglobin (Hp), and beta(2) microglobulin (beta(2)MG). Disease activity was assessed according to the BASDAI, which includes a 10-point visual analogue scale to measure pain, fatigue, morning stiffness, swelling, and areas of local tenderness. Results: When APR values were analyzed for the BASDAI, a positive correlation between CRP and BASDAI was observed (r = 0.556, P < 0.05). There was no clear, statistically significant correlation between BASDAI and the other APRs (ESR, r = 0.328, P > 0.05; Hp, r = 0.035, P > 0.05; and beta(2)MG, r = -0.190, P > 0.05). Conclusions: Our data suggest that CRP is a better marker of disease activity than ESR, Hp, and beta(2)MG.
引用
收藏
页码:350 / 353
页数:4
相关论文
共 24 条
[1]  
ARNETT FC, 1987, B RHEUM DIS, V37, P1
[2]   C-REACTIVE PROTEIN-LEVELS AS A DIRECT INDICATOR OF INTERLEUKIN-6 LEVELS IN HUMANS INVIVO [J].
BATAILLE, R ;
KLEIN, B .
ARTHRITIS AND RHEUMATISM, 1992, 35 (08) :982-983
[3]  
BERGGARD I, 1968, J BIOL CHEM, V243, P4095
[4]  
Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.3.CO
[5]  
2-7
[6]  
Brigden ML, 1999, AM FAM PHYSICIAN, V60, P1443
[7]  
Dougados M, 1999, J RHEUMATOL, V26, P971
[8]  
ElKhoury GY, 1996, RADIOL CLIN N AM, V34, P343
[9]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[10]  
GARRETT S, 1994, J RHEUMATOL, V21, P2286